Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/11216
Title: Insights in the autoimmunity of myasthenia gravis
Authors: DE BAETS, Marc 
Issue Date: 2010
Publisher: TAYLOR & FRANCIS LTD
Source: AUTOIMMUNITY, 43 (5-6). p. 341-343
Abstract: Myasthenia gravis is a prototype anti-receptor autoimmune disease. Antibodies against proteins at the neuromuscular junction cause a defect in the signal transmission from nerve terminal to the damaged postsynaptic membrane. This issue of Autoimmunity reviews the mechanisms that lead to the destruction of the neuromuscular junction and the role of the thymus in myasthenia gravis and its animal models. In addition, this issue explores recent advances in diagnosis and treatment of this disease.
Notes: [De Baets, Marc H.] Univ Maastricht, Div Neurosci, Sch Mental Hlth & Neurosci, Neuroimmunol Grp,Dept Neurosci, NL-6200 MD Maastricht, Netherlands. [De Baets, Marc H.] Hasselt Univ, Biomed Res Inst BIOMED, Neuroimmunol Grp, Diepenbeek, Belgium. m.debaets@maastrichtuniversity.nl
Keywords: Myasthenia gravis; autoimmunity; acetylcholine receptor; muscle-specific tyrosine kinase; neuromuscular;Myasthenia gravis; autoimmunity; acetylcholine receptor; muscle-specific tyrosine kinase; neuromuscular
Document URI: http://hdl.handle.net/1942/11216
ISSN: 0891-6934
e-ISSN: 1607-842X
DOI: 10.3109/08916931003592307
ISI #: 000281961100001
Category: A1
Type: Journal Contribution
Validations: ecoom 2011
Appears in Collections:Research publications

Show full item record

SCOPUSTM   
Citations

5
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

4
checked on May 22, 2022

Page view(s)

42
checked on May 22, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.